EHA Library - The official digital education library of European Hematology Association (EHA)

IS CD45 EXPRESSION LEVEL RELATED TO HIGH RISK DEFINITION IN CHILDHOOD PEDIATRIC B ALL ?
Author(s): ,
Davut Albayrak
Affiliations:
Pediatric Hematology Department,Samsun 19May University Faculty Of Medicine,Samsun,Turkey
Canan Albayrak
Affiliations:
Pediatric Hematology Department,Samsun Ondokuz Mayis University Faculty Of Medicine,Samsun,Turkey
(Abstract release date: 05/21/15) EHA Library. Albayrak D. 06/12/15; 103006; PB1619 Disclosure(s): Samsun Ondokuz Mayis University Faculty Of Medicine
Pediatric Hematology Department
Davut Albayrak
Davut Albayrak
Contributions
Abstract
Abstract: PB1619

Type: Publication Only

Background
Two report shows CD45 brightnes of childhood ALL blast is associated with poor prognosis. Borowitz et al showed that bright CD45 expression was associated with a poor prognosis in BCP-ALL patients treated according to theprotocols of the Pediatric Oncology Groupstudy group and  Cario et al also  in  ALL-BFM-2000 protocol.

Aims
In the present study, we assessed the relation of brightness of CD45 expression in pediatric ALL patients treated according to he ALL-IC-BFM 2009 protocol.

Methods
The brightness of CD45 expression was compared in ten patients of high risk group and ten patient of standart and intermediate groups. In the ALL-IC BFM 2009 trial, the high-risk group was defined by poor prednisone response on treatment day 8, FCM blast ratio >%10 at day 15 and BCR-ABL OR MLL positivity. The brightness of CD45 expression was evaluated as mean flouresence index (MFI).

Results
CD45 MFI was 710,2 for blast,  13784,6 for normal lymphocytes,  0,056 for blast/lymphocytes in hr group, CD45 MFI was 590 for blast,  7904,4 for normal lymphocytes, 0,082 fr blast/lymphocytes in hr group. The differenceb between groups was not significantly different.

Summary
In conclusion, the CD45 brightnes of childhood BCP-ALL did nod have any additional contribution to high risk stratification. This result is different from previous reports. New reports is required to solve this debate.

Session topic: Publication Only
Abstract: PB1619

Type: Publication Only

Background
Two report shows CD45 brightnes of childhood ALL blast is associated with poor prognosis. Borowitz et al showed that bright CD45 expression was associated with a poor prognosis in BCP-ALL patients treated according to theprotocols of the Pediatric Oncology Groupstudy group and  Cario et al also  in  ALL-BFM-2000 protocol.

Aims
In the present study, we assessed the relation of brightness of CD45 expression in pediatric ALL patients treated according to he ALL-IC-BFM 2009 protocol.

Methods
The brightness of CD45 expression was compared in ten patients of high risk group and ten patient of standart and intermediate groups. In the ALL-IC BFM 2009 trial, the high-risk group was defined by poor prednisone response on treatment day 8, FCM blast ratio >%10 at day 15 and BCR-ABL OR MLL positivity. The brightness of CD45 expression was evaluated as mean flouresence index (MFI).

Results
CD45 MFI was 710,2 for blast,  13784,6 for normal lymphocytes,  0,056 for blast/lymphocytes in hr group, CD45 MFI was 590 for blast,  7904,4 for normal lymphocytes, 0,082 fr blast/lymphocytes in hr group. The differenceb between groups was not significantly different.

Summary
In conclusion, the CD45 brightnes of childhood BCP-ALL did nod have any additional contribution to high risk stratification. This result is different from previous reports. New reports is required to solve this debate.

Session topic: Publication Only

By clicking “Accept Terms & all Cookies” or by continuing to browse, you agree to the storing of third-party cookies on your device to enhance your user experience and agree to the user terms and conditions of this learning management system (LMS).

Cookie Settings
Accept Terms & all Cookies